What is Visie?
Visie operates at the intersection of deep tech and clinical excellence, specializing in 3D computer vision systems tailored for orthopaedic, neuro, and spine surgery. By integrating proprietary imaging hardware with sophisticated software algorithms, the company provides surgeons with enhanced visual clarity during complex procedures. This technological edge is designed to mitigate operational risks and improve patient outcomes, positioning Visie as a critical infrastructure provider in the modern operating room. The company's focus on high-stakes surgical environments highlights its commitment to precision medicine and the digital transformation of healthcare delivery.
How much funding has Visie raised?
Visie has raised a total of $3M across 1 funding round:
Debt
$3M
Debt (2025): $3M, investors not publicly disclosed
Key Investors in Visie
Visie
Undisclosed investor participating in the funding round.
What's next for Visie?
With this major enterprise-level funding, Visie is poised to scale its manufacturing capabilities and expand its clinical footprint. The strategic allocation of this capital will likely prioritize the refinement of its imaging hardware and the pursuit of regulatory milestones necessary for broader market adoption. As the company transitions into a more mature phase of its lifecycle, the focus will shift toward establishing long-term partnerships with major hospital networks and surgical centers. By leveraging its deep tech expertise, Visie aims to set a new standard for intraoperative guidance, ensuring that its 3D vision systems become an indispensable tool for surgeons worldwide. Future growth will be driven by continuous innovation in sensor technology and the integration of AI-driven diagnostic features.
See full Visie company page
